figuring out the actual risk of COX-2 inhibitors

March 2005

Experts are getting closer to figuring out the actual risk of COX-2 inhibitors...and how to use them appropriately.

The FDA will leave them on the market...with significant warnings.

Vioxx might even come back, now that we know cardiovascular problems aren't unique to Vioxx...and it's the ONLY one so far that has proven GI benefits.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

figuring out the actual risk of COX-2 inhibitors
Sudafed PE, a new version that DOESN'T contain pseudoephedrine
Are all inhalation devices equally effective
Cardiology concerns about Plavix and GI bleeding
Insomnia a new sleeping pill called Lunesta
new concern over Adderall (mixed amphetamines)
guidelines for treating migraines in CHILDREN
Neurology & Pain Palladone, the first long-acting oral hydromorphone
Gastroenterology whether chronic use of stimulant laxatives is harmful
Gastroenterology Is it important for patients to avoid aspirin and NSAIDs before fecal occult blood tests (Hemoccult, etc)
Gastroenterology if drug doses need to be different after gastric bypass surgery
Dermatology benzoyl peroxide often works as well as oral minocycline for mild to moderate facial acne
HIV & AIDS new recommendations for preventing HIV immediately AFTER an exposure
Drug Testing People are asking about drug testing

figuring out the actual risk of COX-2 inhibitors

Practical advice for a better career, with unlimited access to CE

Table of Contents